COVID-19 update: July 21, 2022

New FDA announcements:

• FDA authorizes state-licensed pharmacists to prescribe Paxlovid to eligible patients, with certain limitations to ensure appropriate patient assessment.
• FDA authorizes use of Novavax COVID-19 vaccine, Adjuvanted for the prevention of COVID-19 in individuals 18 years of age and older.

Summer 2022 regional meetings to be in-person

Thank you for your support of virtual Regional Meetings over the past two years – we had record attendance. To continue maximizing accessibility for attendees, a virtual option will remain available as we return to meeting in-person.

The latest data on organ donation and transplant in the U.S.

Find high-level data on transplants, deceased donors recovered, patients added to the waitlist and patients temporarily moved to inactive waitlist status.

---

Reminders

CDC releases interim recommendations for use of Moderna and Pfizer-BioNTech vaccines for children from 6 months of age

• The CDC’s Advisory Committee on Immunization Practices has issued interim recommendations for the use of COVID-19 vaccines in children from 6 months of age. Read the release.

FDA recommends inclusion of Omicron BA.4/5 component for COVID-19 vaccine boosters

• An FDA advisory committee voted in favor of including a SARS-CoV-2 omicron component in COVID-19 vaccine boosters in the U.S. beginning in fall 2022.

---

New resources

COVID-19 and the transplant community: Answering your questions on treatment and prevention

The American Society of Transplantation (AST) hosted a virtual event on July 7, 2022 to share the latest updates on COVID-19 and transplantation. Watch recording.

---

Questions

• For COVID-19 related policy and operational questions, email [email protected]
• For information and updates about the status of in-person vs. virtual OPTN committee meetings, check the OPTN calendar of events.